Miriam Lerner M.Sc. - Co CEO, CTO

Mrs. Lerner Received her MSc in applied microbiology from the Hebrew University of Jerusalem. For over 20 years she has been involved in the R&D of diagnostic technologies, previously holding senior management positions in 2 companies from their establishment stage. She is experienced in leading project and research teams, as well as in managing QMS. Miriam has co-authored several scientific publications relating to her research.

 

Gil Pogozelich Ph.D. - Chairman

Dr. Pogozelich is highly experienced, for 20 years has been leading successful technology startups. Now specializes in the development, integration and commercialization of Life Science technologies, with emphasis on the field of personalized medicine. Previously specialized in the management of complex development teams in algorithms and engineering, and registered and co-registered a number of patents.

 

Prof. Dedi Meiri - Consultant

Prof. Meiri  is a lecturer, researcher and a member of the Technion faculty in the field of Cancer Biology and Cannabinoid Research- technological and business entrepreneurship, medical implications and methods of growth. He holds a master’s degree in biochemistry, a doctorate in plant biotechnology from Tel Aviv University and a post-doctorate from the Cancer Institute in Toronto. He has published five articles on pancreatic cancer, ovarian cancer, and cancerous metastasis

Dr. Roy Eldor, M.D.- Consultant

Dr. Eldor is the director of the Diabetes Unit in the institute for Endocrinology, Metabolism and Hypertension, in the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and the director of the Central District Diabetes Clinic,  Leumit HMO, Israel. Endocrinologist, internist and researcher with over twenty years of clinical, academic and scientific experience. Principal Scientist in Late Stage Development- Clinical Research Diabetes & Endocrinology, Merck Research Laboratories (MRL), Rahway, NJ, USA. Recognized expert, with over 40 peer reviewed papers and book chapters and invited speaker in international meetings.

Raphael Nir Ph.D. Co-Founder

Dr. Nir is a scientist, entrepreneur and angel investor with over 26 years of experience commercializing recombinant cytokines and pre-clinical contract research services. He is the co-founder of two pre-clinical contract research organizations: SBH Sciences and Woodland Biosciences; and three biotechnology companies: Karyopharm Therapeutics (NASDAQ: KPTI), Galectin Sciences and Alma Bio Therapeutics.

 

Prof.  Michal Baniyash - Inventor

Prof. Baniyash received her Ph.D. in Immunology from the Weizmann Institute of Science, currently a lecturer and principle investigator in the Department of Immunology and Cancer Research at the Hebrew University of Jerusalem, with more than 20 years of experience leading immunological  research on mechanisms and clinical implications of chronic inflammation and suppression of the immune system in various diseases the discovery of new molecules in normal conditions and chronic diseases. She has over 50 publications in prestigious medical journals and numerous inventions on the field of biomarkers.